These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18632214)

  • 21. Impact of adding concomitant chemotherapy to hyperfractionated accelerated radiotherapy for advanced head-and-neck squamous cell carcinoma.
    Nuyts S; Dirix P; Clement PM; Poorten VV; Delaere P; Schoenaers J; Hermans R; Van den Bogaert W
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1088-95. PubMed ID: 18707823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlations between neoadjuvant treatment, anemia, and perioperative complications in patients undergoing esophagectomy for cancer.
    Melis M; McLoughlin JM; Dean EM; Siegel EM; Weber JM; Shah N; Kelley ST; Karl RC
    J Surg Res; 2009 May; 153(1):114-20. PubMed ID: 19201421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prognostic value of hemoglobin concentration in postoperative radiotherapy of 835 patients with laryngeal cancer.
    Rutkowski T; Suwinski R; Idasiak A
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1018-23. PubMed ID: 17716825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased hearing after combined modality therapy for head and neck cancer.
    Pearson SE; Meyer AC; Adams GL; Ondrey FG
    Am J Otolaryngol; 2006; 27(2):76-80. PubMed ID: 16500467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic chemotherapy with cisplatin plus 5-FU (PF) for recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): efficacy and safety of a lower dose of PF (80/800) at a single institution in Japan.
    Kiyota N; Tahara M; Kadowaki S; Fuse N; Doi T; Minami H; Ohtsu A
    Jpn J Clin Oncol; 2009 Apr; 39(4):225-30. PubMed ID: 19211574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small cell carcinoma of the head and neck: the university of Miami experience.
    Hatoum GF; Patton B; Takita C; Abdel-Wahab M; LaFave K; Weed D; Reis IM
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):477-81. PubMed ID: 19004574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postoperative reduced dose of cisplatin concomitant with radiation therapy in high- risk head and neck squamous cell carcinoma.
    Franchin G; Minatel E; Politi D; Gobitti C; Talamini R; Vaccher E; Savignano MG; Trovo M; Sulfaro S; Barzan L
    Cancer; 2009 Jun; 115(11):2464-71. PubMed ID: 19280588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Five years' experience treating locally advanced cervical cancer with concurrent chemoradiotherapy and high-dose-rate brachytherapy: results from a single institution.
    Parker K; Gallop-Evans E; Hanna L; Adams M
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):140-6. PubMed ID: 18922646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic factors in patients with recurrent head and neck cancer treated with reirradiation.
    Krstevska V; Tolevska C; Zafirova-Ivanova B; Stojkovski I; Crvenkova S
    J BUON; 2008; 13(3):369-76. PubMed ID: 18979552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical result of thermochemoradiotherapy for advanced head and neck cancer].
    Hoshina H; Takagi R; Tsurumaki H; Nagashima K; Miyaura Y; Fujita H; Miyamoto T; Sohma Y; Iida A; Nagata M; Kaji M
    Gan To Kagaku Ryoho; 2001 Mar; 28(3):331-6. PubMed ID: 11265400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term results of radiation therapy oncology group 9903: a randomized phase 3 trial to assess the effect of erythropoietin on local-regional control in anemic patients treated with radiation therapy for squamous cell carcinoma of the head and neck.
    Shenouda G; Zhang Q; Ang KK; Machtay M; Parliament MB; Hershock D; Suntharalingam M; Lin A; Rotman M; Nabid A; Hong S; Shehata S; Cmelak AJ; Sultanem K; Le QT
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):907-15. PubMed ID: 25670542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis : results from a Northwestern University Costs of Cancer Program pilot study with head and neck and nonsmall cell lung cancer patients who received care at a county hospital, a Veterans Administration hospital, or a comprehensive cancer care center.
    Nonzee NJ; Dandade NA; Patel U; Markossian T; Agulnik M; Argiris A; Patel JD; Kern RC; Munshi HG; Calhoun EA; Bennett CL
    Cancer; 2008 Sep; 113(6):1446-52. PubMed ID: 18683883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of primary tumor volume after concurrent chemoradiation with daily low-dose cisplatin for advanced-stage head and neck carcinoma.
    Hoebers FJ; Pameijer FA; de Bois J; Heemsbergen W; Balm AJ; Schornagel JH; Rasch CR
    Head Neck; 2008 Sep; 30(9):1216-23. PubMed ID: 18642295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer.
    Caudell JJ; Schaner PE; Meredith RF; Locher JL; Nabell LM; Carroll WR; Magnuson JS; Spencer SA; Bonner JA
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):410-5. PubMed ID: 18635320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The comparison of weekly and three-weekly cisplatin chemotherapy concurrent with radiotherapy in patients with previously untreated inoperable non-metastatic squamous cell carcinoma of the head and neck.
    Uygun K; Bilici A; Karagol H; Caloglu M; Cicin I; Aksu G; Fayda M; Uzunoglu S
    Cancer Chemother Pharmacol; 2009 Aug; 64(3):601-5. PubMed ID: 19123002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors associated with radiation-induced nausea and vomiting in head and neck cancer patients treated with intensity modulated radiation therapy.
    Monroe AT; Reddy SC; Gibbs GL; White GA; Peddada AV
    Radiother Oncol; 2008 May; 87(2):188-94. PubMed ID: 18237801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
    Finnegan V; Parsons JT; Greene BD; Sharma V
    Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Anemia in head and neck cancers].
    Azria D; Zouhair A; Serre A; Lemanski C; Schneider M; Ozsahin M; Dubois JB; Lartigau E;
    Bull Cancer; 2005 May; 92(5):445-51. PubMed ID: 15932808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors for survival after salvage reirradiation of head and neck cancer.
    Tanvetyanon T; Padhya T; McCaffrey J; Zhu W; Boulware D; Deconti R; Trotti A
    J Clin Oncol; 2009 Apr; 27(12):1983-91. PubMed ID: 19289616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Honey as topical prophylaxis against radiochemotherapy-induced mucositis in head and neck cancer.
    Rashad UM; Al-Gezawy SM; El-Gezawy E; Azzaz AN
    J Laryngol Otol; 2009 Feb; 123(2):223-8. PubMed ID: 18485252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.